RENEE WILLIAMS: Open Payments
NPI 1962877852 · BELLA VISTA, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,522 in 81 payments from 21 companies in 2025. Trend: 2023 $1,726 · 2024 $1,498 · 2025 $1,522
Food & beverage: $1,522
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $367 |
| AstraZeneca Pharmaceuticals LP | 3 | $158 |
| Amgen Inc. | 12 | $153 |
| Astellas Pharma US Inc | 6 | $110 |
| Cepheid | 1 | $110 |
| Novo Nordisk Inc | 5 | $84 |
| Phathom Pharmaceuticals, Inc. | 5 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $70 |
| Dexcom, Inc. | 4 | $70 |
| PFIZER INC. | 3 | $59 |
Products named: QULIPTA, FARXIGA, Veozah, GeneXpert, OTEZLA, VOQUEZNA, Kerendia, Dexcom G6 Transmitter.
Industry payments across AR — which companies pay providers there.
